159 related articles for article (PubMed ID: 38379304)
1. Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus.
Cho SY; Lee YJ; Jung SM; Son YM; Shin CG; Kim ET; Kim KD
J Microbiol Biotechnol; 2024 Apr; 34(4):804-811. PubMed ID: 38379304
[TBL] [Abstract][Full Text] [Related]
2. Transient foamy virus vector production by adenovirus vectors.
Russell RA; Vassaux G; Martin-Duque P; McClure MO
Gene Ther; 2004 Feb; 11(3):310-6. PubMed ID: 14737091
[TBL] [Abstract][Full Text] [Related]
3. Delivery of large transgene cassettes by foamy virus vector.
Sweeney NP; Meng J; Patterson H; Morgan JE; McClure M
Sci Rep; 2017 Aug; 7(1):8085. PubMed ID: 28808269
[TBL] [Abstract][Full Text] [Related]
4. Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.
Weber C; Armbruster N; Scheller C; Kreppel F; Kochanek S; Rethwilm A; Steinert AF
J Gene Med; 2013; 15(3-4):155-67. PubMed ID: 23554302
[TBL] [Abstract][Full Text] [Related]
5. Foamy virus vectors.
Mergia A; Heinkelein M
Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
[TBL] [Abstract][Full Text] [Related]
6. Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.
Hamann MV; Stanke N; Müllers E; Stirnnagel K; Hütter S; Artegiani B; Bragado Alonso S; Calegari F; Lindemann D
Mol Ther; 2014 Aug; 22(8):1460-1471. PubMed ID: 24814152
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo gene delivery to synovium using foamy viral vectors.
Armbruster N; Weber C; Wictorowicz T; Rethwilm A; Scheller C; Steinert AF
J Gene Med; 2014; 16(7-8):166-78. PubMed ID: 25044583
[TBL] [Abstract][Full Text] [Related]
8. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
9. Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles.
Stirnnagel K; Schupp D; Dupont A; Kudryavtsev V; Reh J; Müllers E; Lamb DC; Lindemann D
Retrovirology; 2012 Aug; 9():71. PubMed ID: 22935135
[TBL] [Abstract][Full Text] [Related]
10. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.
Picard-Maureau M; Jarmy G; Berg A; Rethwilm A; Lindemann D
J Virol; 2003 Apr; 77(8):4722-30. PubMed ID: 12663779
[TBL] [Abstract][Full Text] [Related]
11. SGK1, a Serine/Threonine Kinase, Inhibits Prototype Foamy Virus Replication.
Zhang J; Han C; Xiong Z; Qiu M; Tuo X; Wang C; Qiao W; Tan J
Microbiol Spectr; 2022 Jun; 10(3):e0199521. PubMed ID: 35438526
[TBL] [Abstract][Full Text] [Related]
12. Dual transgene expression by foamy virus vectors carrying an endogenous bidirectional promoter.
Andrianaki A; Siapati EK; Hirata RK; Russell DW; Vassilopoulos G
Gene Ther; 2010 Mar; 17(3):380-8. PubMed ID: 19907502
[TBL] [Abstract][Full Text] [Related]
13. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
14. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
15. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
Ho YP; Schnabel V; Swiersy A; Stirnnagel K; Lindemann D
Mol Ther; 2012 Jun; 20(6):1167-76. PubMed ID: 22472951
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy.
Loeb JE; Cordier WS; Harris ME; Weitzman MD; Hope TJ
Hum Gene Ther; 1999 Sep; 10(14):2295-305. PubMed ID: 10515449
[TBL] [Abstract][Full Text] [Related]
17. An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity.
Reh J; Stange A; Götz A; Rönitz M; Große A; Lindemann D
Retrovirology; 2013 Apr; 10():45. PubMed ID: 23618494
[TBL] [Abstract][Full Text] [Related]
18. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
19. Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells.
Zhang Y; Liu Y; Zhu G; Qiu Y; Peng B; Yin J; Liu W; He X
J Neurovirol; 2010 Nov; 16(6):419-26. PubMed ID: 20969536
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
